12,500 Shares in The Cooper Companies, Inc. $COO Purchased by Bluefin Capital Management LLC

Bluefin Capital Management LLC bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 12,500 shares of the medical device company’s stock, valued at approximately $896,000.

Several other institutional investors and hedge funds also recently modified their holdings of COO. BlackRock Inc. acquired a new position in shares of Cooper Companies during the 2nd quarter worth approximately $1,077,762,000. State Street Corp grew its holdings in Cooper Companies by 2.4% during the 4th quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock valued at $720,736,000 after buying an additional 207,195 shares during the last quarter. Wellington Management Group LLP grew its holdings in Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after buying an additional 4,756,178 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in Cooper Companies by 58.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after buying an additional 2,231,568 shares in the last quarter. Finally, Generation Investment Management LLP purchased a new position in Cooper Companies during the second quarter worth $356,304,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

COO has been the topic of a number of recent research reports. Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. Stifel Nicolaus lowered their price target on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a report on Friday, June 5th. Citigroup reissued a “neutral” rating and issued a $80.00 price objective (up from $76.00) on shares of Cooper Companies in a research report on Thursday, August 13th. Wells Fargo & Company restated a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Finally, Needham & Company LLC lowered their target price on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research note on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $81.64.

Cooper Companies Trading Down 0.5%

Shares of COO opened at $72.68 on Thursday. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83. The stock’s 50-day moving average is $72.36 and its two-hundred day moving average is $70.96. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The stock has a market cap of $14.17 billion, a PE ratio of 61.59, a P/E/G ratio of 1.91 and a beta of 0.83.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.